Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
---|---|
Contact name | Peter Yuen |
Contact phone | 301-402-6702 |
Contact email | petery@intra.niddk.nih.gov |
Dua signed dt | May 11, 2009, midnight |
Niddk signed dt | May 20, 2009, midnight |